A detailed history of Avantax Advisory Services, Inc. transactions in Iradimed Corp stock. As of the latest transaction made, Avantax Advisory Services, Inc. holds 4,465 shares of IRMD stock, worth $320,051. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,465
Previous 4,546 1.78%
Holding current value
$320,051
Previous $238,000 11.76%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2025

Aug 08, 2025

SELL
$48.67 - $60.8 $3,942 - $4,924
-81 Reduced 1.78%
4,465 $266,000
Q1 2025

May 06, 2025

BUY
$51.44 - $62.67 $30,812 - $37,539
599 Added 15.18%
4,546 $238,000
Q4 2024

Feb 07, 2025

BUY
$48.3 - $57.35 $190,640 - $226,360
3,947 New
3,947 $217,000

Others Institutions Holding IRMD

About IRADIMED CORP


  • Ticker IRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 12,565,100
  • Market Cap $901M
  • Description
  • IRADIMED CORPORATION develops, manufactures, markets, and distributes magnetic resonance imaging (MRI) compatible medical devices, and related accessories and services in the United States and internationally. It offers MRidium MRI compatible intravenous (IV) infusion pump system with associated disposable IV tubing sets; and MRI compatible pati...
More about IRMD
Track This Portfolio

Track Avantax Advisory Services, Inc. Portfolio

Follow Avantax Advisory Services, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Avantax Advisory Services, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Avantax Advisory Services, Inc. with notifications on news.